Come up with a name for your new list and we'll add to it:
Alvos Therapeutics was acquired by
Arrowhead Research on April 12, 2012.
Alvos Therapeutics is a biopharmaceutical provider to use in vivo phage display technology systematically to develop novel cancer drugs. Alvos was founded to translate the research into effective canc…